share_log

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $34

Benzinga Real-time News ·  Feb 3, 2023 06:14

SVB Leerink analyst Joseph Schwartz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and raises the price target from $33 to $34.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment